Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) EPS (Basic) (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of EPS (Basic) data on record, last reported at $0.82 in Q3 2025.

  • For Q3 2025, EPS (Basic) fell 20.39% year-over-year to $0.82; the TTM value through Sep 2025 reached $3.54, down 17.29%, while the annual FY2024 figure was $3.96, 13.54% down from the prior year.
  • EPS (Basic) reached $0.82 in Q3 2025 per UTMD's latest filing, down from $0.94 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.25 in Q4 2022 and bottomed at $0.82 in Q3 2025.
  • Average EPS (Basic) over 5 years is $1.04, with a median of $1.08 recorded in 2023.
  • Peak YoY movement for EPS (Basic): soared 161.11% in 2021, then fell 27.12% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $1.13 in 2021, then rose by 10.62% to $1.25 in 2022, then fell by 5.6% to $1.18 in 2023, then fell by 27.12% to $0.86 in 2024, then decreased by 4.65% to $0.82 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $0.82 in Q3 2025, $0.94 in Q2 2025, and $0.92 in Q1 2025.